Ali Esparham

Mashhad University of Medical Sciences

Papers

1

Total Citations

2

H-Index

1

About

Ali Esparham is a rising researcher in surgical oncology and gastrointestinal cancer epidemiology, with a focus on gastric adenocarcinoma outcomes. His most-cited work, a 2025 study examining clinicopathologic and treatment trends in gastric adenocarcinoma patients in the United States from 2004 to 2021, has already garnered early attention with 2 citations. This research provides critical insights into evolving diagnostic patterns, shifts in treatment modalities, and survival disparities over nearly two decades, offering a comprehensive analysis that informs clinical practice and public health strategies. Esparham’s contributions highlight the importance of large-scale, longitudinal data in understanding cancer care evolution, particularly for aggressive malignancies like gastric cancer. His work is notable for its timeliness, addressing gaps in contemporary U.S. cancer trends, and its potential to guide future therapeutic approaches. As an emerging voice in the field, Esparham’s research underscores a commitment to improving patient outcomes through evidence-based, population-level analysis, making his findings valuable for clinicians, epidemiologists, and oncology researchers alike.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Trends in Clinicopathologic and Treatment Outcomes in Patients with Gastric Adenocarcinoma in the United States Between 2004 and 2021
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Mashhad University of Medical Sciences

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago